Over 6100 hip resurfacings:
- one of the first surgeons in the US to begin metal-on-metal hip resurfacing in 1999
- led the first US FDA trial on hip resurfacing leading to approval of the Corin Cormet 2000 device in 2007.
- developed the Biomet Magnum and recap systems for hip replacement and resurfacing and began using these in 2005.
- began using the worlds first completely uncemented Biomet system for resurfacing in 2007. And have performed over 5000 uncemented resurfacings to date, while most surgeons still rely on inferior cement fixation of the femoral component.
Do our competitors post their results online?
The most important factor in achieving a successful result is the surgeon’s skill. You can only assess this from published data. We publish our results in scientific journals (educational material / scientific publications). Our most recent up-to-date data are available on this website (educational material / latest data). 99% 13-year implant survivorship in 5050 cases using the Biomet uncemented resurfacing system (99.3% in men and 98.3% in women). These are results in all comers... not just selected lowest risk patients (men with osteoarthritis). This compares favorably with the recent National Joint Registry report from Great Britain where a similar 92% overall 8-10 year survivorship is reported for both the cemented Biomet and BHR hip resurfacing systems.
Advances in technology have now allowed us to begin offering all joint replacement surgery in an outpatient setting for selected young healthy patients. We began offering this in 2012 for selected local resurfacing patients. We have now expanded this offer to out-of-state patients. Minimally invasive techniques that allow a faster recovery, better pain control, and no transfusions have made this possible. Many people prefer avoiding a hospital to have their joint repaired. It is also more cost-effective. Local patients return directly home after day surgery, out-of-state patients stay in a hotel for 1-2 night before travelling home.